Practice Areas
For more than 20 years, Amanda Austin has provided sophisticated strategic counsel on transactions involving many of the life sciences industry’s most important emerging technologies. Her practice includes a full range of life sciences transactions, including co-development and co-commercialization licensing and collaboration arrangements, research and development collaboration agreements, strategic licensing partnerships, joint ventures, co-promotion relationships, and complex distribution and manufacturing arrangements. She also advises on intellectual property-related matters related to M&A transactions in the life sciences industry.
Amanda represents and counsels multinational pharmaceutical companies, biotechnology and synthetic biology companies, startups and early-stage enterprises, medical device companies, nonprofit organizations, and academic institutions in transactions critical to their business and mission, including innovatively structured deals and cross-border transactions.